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Abstract
Background: The human body has an extensive capacity to regenerate bone tissue after trauma. However large
defects such as long bone fractures of the lower limbs cannot be restored without intervention and often lead to
nonunion. Therefore, the aim of the present study was to assess the pool and biological functions of human
mesenchymal stromal cells (hMSCs) isolated from different bone marrow locations of the lower limbs and to
identify novel strategies to prime the cells prior to their use in bone fracture healing. Following, bone marrow from
the ilium, proximal femur, distal femur and proximal tibia was aspirated and the hMSCs isolated. Bone marrow type,
volume, number of mononuclear cells/hMSCs and their self-renewal, multilineage potential, extracellular matrix
(ECM) production and surface marker profiling were analyzed. Additionally, the cells were primed to accelerate
bone fracture healing either by using acoustic stimulation or varying the initial hMSCs isolation conditions.
Results: We found that the more proximal the bone marrow aspiration location, the larger the bone marrow
volume was, the higher the content in mononuclear cells/hMSCs and the higher the self-renewal and osteogenic
differentiation potential of the isolated hMSCs were. Acoustic stimulation of bone marrow, as well as the isolation
of hMSCs in the absence of fetal bovine serum, increased the osteogenic and ECM production potential of the cells,
respectively.
Conclusion: We showed that bone marrow properties change with the aspiration location, potentially explaining
the differences in bone fracture healing between the tibia and the femur. Furthermore, we showed two new
priming methods capable of enhancing bone fracture healing.
Keywords: Bone marrow, hMSCs, Acoustic stimulation, Cell priming
Background
Musculoskeletal disorders affect the body’s muscles,
bones, joints, tendons, ligaments and nerves and are the
leading cause of chronic disabilities in adults [1]. Signifi-
cant research efforts have been undertaken during the last
decades to ease this disability and improve patient’s mobil-
ity and quality of life. Bone fracture repairs have been
intensively investigated at both clinical and fundamental
level and still 5-10% of fractures resulted in either delayed
repair (delayed union) or no repair (nonunion) [2]. At
present there are two primary treatment strategies: (1)
surgical intervention that implies the use of bone
autograft/allografts, demineralized bone matrix or syn-
thetic materials and (2) noninvasive treatments such as
the application of acoustic energy shown to be beneficial
in fracture healing [3, 4]. Nevertheless, these strategies rely
on the patient’s own cells – either stem and/or commit-
ted- to induce bone regeneration, posing a challenge in
situation whereas those cells are missing and/or less
active. In these cases cell-based alternatives, such as the
use of human mesenchymal stromal cells (hMSCs) were
proposed [5].
In this study we explored the yield, proliferation, mul-
tilineage differentiation and extracellular matrix (ECM)
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production potential of hMSCs isolated from bone mar-
row (BM) aspirated from the lower limbs, such as the
ilium, proximal femur, distal femur and proximal tibia.
Additionally, we examined the inter- and intra-donor
variation between the BM-derived hMSCs from the
different locations. It has been shown that the nonunion
rate in bone fracture healing (BFH) differs with regard to
their location, with fractures at tibia diaphysis healing
slower (nonunion rate of 18.5% [6]) than fractures in the
femoral shaft (nonunion rate of 1.7% [7]). Accordingly,
we hypothesize that BM located at the fracture site
might play an important role in the fracture healing rate,
due to differences in cell number, self-renewal-, prolifer-
ative-, ECM production- and multilineage differentiation
potential.
Additionally, as cell-based therapies are already used
in musculoskeletal pathologies, such as bone fracture,
pseudarthrosis and osteochondral defects [8, 9], we ex-
plored the potential of priming BM-derived hMSCs to-
wards the osteogenic lineage in order to accelerate
tissue regeneration upon reimplantation. We explored
two distinct priming strategies: (1) the use of acoustic
energy applied on BM and (2) varying the initial culture
conditions of the isolated hMSCs.
Ultrasound has been shown to have beneficial effects
on BFH showing an increase in bone formation [10, 11],
however not consistently [12–14]. Moreover, a 42%
acceleration in fracture healing in patients exposed to a
twenty minutes daily ultrasound treatment is still not
optimal [11]. Therefore, we believe that the use of
acoustically stimulated BM injected at the fracture site
might have a greater impact on BFH than the actual
standard ultrasound treatment. Mechanical stimulation
has been shown to pre-commit hMSCs towards the
osteogenic lineage [15] and thus we hypothesize that
acoustic energy applied directly on BM might induce the
commitment of hMSCs towards osteogenesis. It is clinic-
ally feasible and simple to apply a short period of acous-
tic stimulation on a BM aspirate during fracture surgery
after which the BM can be administrated to the fracture
site either in initial surgery during high risk cases or as
an adjuvant to revision surgery in case of pseudarthrosis.
Secondly, cell-based therapies often involve the in
vitro expansion of cells, where the isolation procedure
plays an important role in the selection of desired cell
population [16–18]. The isolation of hMSCs from BM is
mainly achieved by plastic adherence and it is recog-
nized that both the number of mononuclear cells
(MNCs) plated and the culture media have a strong
influence on the selection of certain hMSCs populations
[19]. Accordingly, we hypothesize that low MNCs seed-
ing density might select hMSCs with higher self-renewal
potential, while the use of serum free (SF) media might
select a hMSCs subpopulation with enhanced potency.
The phenotype of the isolated hMSCs under the afore-
mentioned conditions were compared to a previously
described isolation procedure [20].
Following, with this study we aimed to find the opti-
mal ratio between aspirated BM volume and MNCs
concentration, to explain the difference in cell pheno-
type between the different BM locations of the lower
limb extremities and to propose new methods that could
accelerate BFH. A schematic overview of the
experimental design is presented in Fig. 1.
Methods
Aspiration of bone marrow
BM aspirates were obtained from patients undergoing
total hip arthroplasty (THA) or total knee arthroplasty
(TKA). An 8G Jamshidi BM needle fit with a 50-mL
Luer lock syringe containing 1 mL of 1,000 U heparin
per 10 mL BM was used to aspirate the BM.
Subsequently, the BM was transferred to blood collec-
tion tubes (BD-367526) for the transport from the
operating theatre to the laboratory. The BM was kept at
ambient room temperature until processed within the
same day.
BM was aspirated from four different locations: the supra
acetabular sulcus (ilium) in twelve donors, the medullary
cavity or lateral diaphysis of the femur (proximal femur) in
seven donors, and the epiphysis or medullary cavity from
the distal femur or proximal tibia in seven more donors.
Isolation and culture of hMSCs
BM aspirate was passed through a 70 μm pore-size cell
strainer to remove the presence of tissue pieces after
which MNCs concentration from the ilium and proximal
femur was analyzed using the Beckman coulter ACT diff
2. The number of MNCs for samples collected from the
distal femur and proximal tibia was not analyzed due to
technical limitations.
Based on the isolation method used, different concen-
trations of MNCs/cm2 were plated. We defined three
isolation/culture conditions: heterogeneous (classical
MNCs seeding density, previously described and stan-
dardized hMSCs isolation protocol within our laboratory
[21]), multiclonal (low MNCs seeding density, permis-
sive for single cell clonal expansion) and SF (high MNCs
seeding density in the absence of fetal bovine serum
proteins during the initial phase).
For the heterogeneous isolation condition, BM aspirate
was plated at a density of 5x105 MNCs/cm2 and cultured in
growth media (GM) consisting of α-minimal essential media
(αMEM, Life Technologies – Cat. No.: 22571-020), 10%
Fetal Bovine Serum (FBS, Gibco – Cat. No.: 10270106),
0.2 mM L-ascorbic acid 2-phosphate magnesium salt (Sigma
– Cat. No.: A8960), 2 mM L-glutamine (Gibco – Cat. No.:
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BE17-605E), 100 units/mL penicillin and 100 mg/mL
streptomycin (Gibco – Cat. No.: 15140-122).
For the multiclonal isolation condition, BM aspirate
was plated at a clonal density of 5x104 MNCs/cm2 and
cultured in GM.
For the SF condition, BM aspirate was plated at a cell
density of 1.5x106 MNC/cm2 in α-MEM containing no
additives for the first three days.
At the fourth day, the non-adherent cell fraction was
removed and the media was changed to GM for all three
conditions. Hereafter, media was refreshed twice a week.
At semi-confluence cells were trypsinized and used for
sub-culturing or stored in liquid nitrogen for future use.
In total, BM was aspirated from 19 donors and subse-
quently divided between the different experiments. BM
from 14 donors was used to evaluate the most conveni-
ent aspiration site location. BM was plated under het-
erogeneous condition, with exception of distal Femur
and proximal Tibia where 2 ml BM was plated each
time, as the initial amount of MNCs was unknown. BM
Fig. 1 Schematic representation of the experimental design. Aspiration of BM from different locations of the lower limb extremities and selection
of the optimal cell source, based on hMSC number and phenotype. In vitro priming of hMSC by use of acoustic stimulation or varying the initial
culture conditions with the final aim to enhance in vivo bone fracture healing
Ghebes et al. BMC Biotechnology  (2016) 16:89 Page 3 of 13
from 11 donors was plated in heterogenous condition
and used to evaluate the effects of acoustic en-
ergy stimulation and BM from 6 donors was used to
evaluate the effects of varying the initial isolation
conditions of the hMSCs.
Donor number, BM aspiration location, BM volume
and concentration of MNCs/ml can be found in Table 1.
BM was cultured at 37 °C and 5% CO2.
hMSCs population doubling
To assess hMSC proliferation, cells from passage 1 (P1)
were seeded in GM at 5 000 cells/cm2 in T175 tissue
culture flasks. At semi confluence the cells were trypsi-
nized and counted. Population doubling (PD) was calcu-
lated according to the formula PD = log2(NE/Ni), where
NE and NI are the number of hMSCs obtained at
passage 2 (P2) and P1, respectively.
Colony forming unit and colony forming unit-osteoblast
potential (mineralization)
The colony forming unit (CFU) assay was used as an indi-
cator of self-renewal potential of the hMSCs and the
CFU-osteoblast (CFU-Ob) assay was used as an indicator
of their osteogenic potential. Two million MNCs were
seeded in duplicate in T25 culture flasks and grown
in GM for the first 7 days, followed by transition to
mineralization media for further 7 days. The
mineralization media consisted of GM containing 0.01 M
β-glycerophosphate (BGP, Sigma – Cat. No.: G9422) and
10-8 M Dexamethasone (Dex, Sigma – Cat. No.: D8893).
At day 14, the cultures were fixed with 10% formalin for
15 min at ambient temperature, after which alkaline phos-
phatase (ALP) positive colonies were stained using the
Leukocyte Alkaline Phosphatase Kit -ALP (Sigma – Cat.
No.: 85 L2) following the manufacturer’s instructions.
Subsequently, colonies were stained using 0.5% Coomassie
Brilliant Blue staining (Fluka – Cat. No.: 27815) solution
for 10 minutes and images of the stained colonies were ac-
quired using an Epson Perfection V750 PRO scanner. The
total number of CFUs and ALP positive colonies was
quantified using ImageJ 1.45 s software and the percentage
of ALP positive CFUs calculated.
Extracellular matrix production
hMSCs at P2 or P3 were seeded in quadruplicate at 100
000 cells/well in a 384-well plate in GM (without serum)
consisting of 50 μg/mL insulin transferrin selenium-
premix (Sigma – Cat. No.: I3146) and 40 μg/mL proline
(Sigma – Cat. No.: P5607) and incubated for 24 h to allow
cell adhesion. The next day the medium was refreshed
and 10 ng/mL transforming growth factor beta 3 (R&D
Systems – Cat. No.: 243-B3) and 10-7 M Dex was added
to the wells. After seven days the formed nodules were
fixed in 10% formalin for 15 min at ambient temperature
and images were captured using a Nikon bright field
microscope. The nodule area and the number of nodules
formed were quantified using ImageJ 1.45 s software. The
early cell condensation phenotype and the increase in
nodule size was associated with ECM production.
Alizarin red staining (mineralization)
hMSCs at P2 or P3 were seeded in triplicate at 50 000
cells/well in T25 and grown in control media consisting











Donor 1 Ilium Red 20 31.6
Donor 2 Ilium Red 35 12.3
Donor 3 Ilium Red 15 17.9
Donor 4 Ilium Red 25 20.2
Donor 5 Ilium Red 30 13.5
Donor 6 Ilium Red 28 6.8
Proximal Femur Red 11.5 16.3
Donor 7 Ilium Red 20 16.1
Proximal Femur Red 1 15.1
Donor 8 Ilium Red 13 34.7
Proximal Femur Red 6 16.2
Donor 9 Ilium Red 20 7.3
Proximal Femur Red 6.5 7.9
Donor 10 Ilium Red 22.5 14.5
Proximal Femur Red 9 22.4
Donor 11 Ilium Red 22.5 7.4
Proximal Femur Red 5 6.4
Donor 12 Ilium Red 7.5 26.6
Proximal Femur Red 5 37
Donor 13 Distal Femur Yellow 3.5 -
Proximal Tibia Yellow 2.5 -
Donor 14 Distal Femur Yellow 5 -
Proximal Tibia Yellow 7.5 -
Donor 15 Distal Femur Yellow 9 -
Proximal Tibia Yellow 3 -
Donor 16 Distal Femur Yellow 2 -
Proximal Tibia Yellow 1.5 -
Donor 17 Distal Femur Yellow 6 -
Proximal Tibia Yellow 7 -
Donor 18 Distal Femur Yellow 8 -
Proximal Tibia Yellow 4.5 -
Donor 19 Distal Femur Yellow 2 -
Proximal Tibia Yellow 2 -
From left to right: donor number, BM aspiration location, type, aspirated
volume and concentration of MNCs/ml
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of GM containing 0.01 M BGP and in mineralization
medium consisting of GM containing 0.01 M BGP and
10-8 M Dex. The media was refreshed twice a week. After
28 days, cells were fixed in 10% formalin for 15 min at
ambient temperature and stained with 2% Alizarin red so-
lution (Sigma – Cat. No.: A5533) for 5 min. Images were
captured using a Nikon bright field microscope.
Oil red O staining (Adipogenesis)
hMSCs at P2 or P3 were seeded in triplicate at 25 000
cells/well in 24-well plates and grown in control medium
consisting of GM or adipogenic medium consisting of
GM containing 0.2 mM indomethacin (Cat. No.: I7378),
0.5 mM isobutylmethylxanthine (Cat. No.: I5879), 10-6
M Dex and 10 μg/mL human insulin (Cat. No.: I9278),
all from Sigma. The media was refreshed twice a week.
After three weeks the cells were fixed with 10% formalin
for 15 min at ambient temperature, after which the cell
monolayer was incubated for 5 min in 60% isopropanol,
and subsequently stained with Oil red O solution (3 mg/
mL in 60% isopropanol, Sigma – Cat. No.: 0625). After
five minutes, samples were rinsed with demineralized
water and images were captured using a Nikon bright
field microscope. After the imaging, Oil red O staining
was extracted from the cells in 4% Nonidet P40 (Fluka,
Cat. No.: 74385) in isopropanol and absorbance was
measured at 540 nm (Lambda 40; Perkin Elmer). One
hundred percent Oil red O was included in the calibra-
tion curve measurements, from which the percentage of
Oil red O staining was calculated.
Flow cytometry
hMSCs at P3 or P4 were expanded in T175 until they
reached confluence. The cells were trypsinized and
incubated for 30 min in blocking buffer consisting of
17% bovine serum albumin (Sigma – Cat. No.: F7524) in
PBS followed by incubation with FITC- or PE-
conjugated mouse anti-human antibodies for 30 min at
4 °C in the dark. The samples were then washed three
times with a washing buffer consisting of 3% bovine
serum albumin in PBS. The expression levels were
analyzed using FACSAria flow cytometer (BD
Bioscience). For phenotypic characterization the follow-
ing antibodies were used: CD90, CD73, CD146, CD105,
CD271, CD34, CD14, CD79a, HLA-DR, CD45 and IgG1
and Ig G2a as isotype controls (all from BD Pharming).
Acoustic stimulation of bone marrow
Acoustic stimulation of BM was achieved using the bone
marrow aspirate concentration device, previously
described by Ridgway et al. [22]. BM was placed into the
processing chamber of the device and acoustic vibration
was applied using a voice-coil which produced a geomet-
ric standing waveform pattern on the BM fluid surface.
Different frequencies were tested by manual adjustment
using an Oscilloscope (Agilent Technologies, InfiniVi-
sion, MSO-X-3014A Mixed Signal Oscilloscope) and
two frequencies, 300 Hz (48 mW/cm2) and 500 Hz
(73 mW/cm2), were selected for further experimental
research. The BM was processed one time for 5 and
10 min for both selected frequencies. The baseline was
defined as unstimulated BM.
Following, part of the BM was plated to assess the
self-renewal and proliferation potential as previously
described, while the rest of the BM was plated under the
heterogeneous hMSCs isolation condition in order to
assess the multilineage differentiation potential, ECM
production and surface markers expression of the
hMSCs at later passage, as previously mentioned.
Bone marrow viscosity
BM viscosity from 6 donors (3 donors for ilium and
proximal femur and 3 donors for distal femur and prox-
imal tibia) was measured using the Rheometer Physica
MCR-301. A total of thirty different points, with an in-
creasing shear rate from 0 to 250 L/s and periodic pause
of 10 s between each point, were measured. The volume
of BM used for the measurements was 350 μl per meas-
uring cycle. All samples were measured in duplicates at
ambient room temperature.
Statistical analysis
Statistical analysis was performed using Graphpad Prism
6 software. Unpaired Student’s t-test and Mann-Whitney
post-test was performed to compare the data when two
groups were analyzed. One-way or two-way ANOVA
and a Tukey or Bonferroni post-test was used to com-
pare the data when more than two groups were
analyzed. The uniform distribution of data, to test inter-
donor variation, was assessed using a Chi-squared test.
A P ≤ 0.05 indicates a statistical significant difference.
The results are shown as mean ± standard deviation.
Results
Inter-donor variability in bone marrow aspirate
The volume of BM aspirated from the different loca-
tions varied significant, with larger BM volumes
obtained from the ilium (22 ± 7.6 ml) than the proximal
femur (6 ± 3.3 ml), distal femur (5 ± 2.9 ml) or proximal
tibia (4 ± 2.6 ml). BM volumes from the ilium yielded a
higher concentration of MNCs for volumes close to
10 ml (2.6 x 107 MNC/ml), while volumes close and
larger than 20 ml yielded a lower concentration of
MNCs (1.4 x 107 MNC/ml), however not statistical sig-
nificant (p = 0.15). Similarly, BM aspirated from prox-
imal femur showed higher MNC yield for volumes
lower than 5 mL, 2 x 107 MNC/mL versus 1.6 x 107
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MNC/mL, however not statistical significant (p = 0.7)
(Fig. 2A and Table 1).
The concentration of hMSCs obtained at the end of
the expansion phase (14 days after MNCs seeding) was
on average 566 494 hMSC/ml for the ilium, 245 549
hMSC/ml for the proximal femur, 76 250 hMSC/ml for
the distal femur and 122 321 hMSC/ml for the proximal
tibia samples (Fig. 2B). No statistical significant differ-
ences were found between the groups, however lower p
values where obtained from hMSCs isolated from prox-
imal versus distal locations (Additional file 1: Table S1).
Macroscopically, the BM aspirated from the ilium and
proximal femur was red, while BM aspirated from distal
femur and proximal tibia was yellow, consistent with a
higher presence of lipid droplets in the latter (Additional
file 2: Figure S1). Compared with the other aspiration
locations we observed a significant decrease in BM
viscosity for BM aspirated from the proximal tibia
(Fig. 2C). The morphological appearance of expanded
hMSCs did not show any visible differences between the
different BM aspiration locations (data not shown).
Effect of aspiration location on biological characteristics
of hMSCs
Proliferation, self-renewal ECM production and multili-
neage potential (osteo- and adipogenic) were assessed
for hMSCs isolated from the different locations (Fig. 3).
Proliferation capacity and ECM production of hMSC
was similar between the different donors regardless of
the BM aspiration location (Fig. 3a, e). An average for all
donors showed a statistical significant increase in prolif-
eration of hMSCs isolated from distal femur (0.64 ±
0.07) and proximal tibia (0.71 ± 0.08) when compared to
the ilium (0.47 ± 0.09) and proximal femur (0.48 ± 0.13)
(Fig. 3b), however no statistical significant differences
were seen in ECM production (Fig. 3f ).
In contrast, the CFU capacity of hMSCs showed a
non-uniform distribution for all the donors, independent
of the BM location (Fig. 3c). An average for all the do-
nors showed a trend towards a higher CFU capacity of
hMSCs isolated from the proximal femur 54 ± 42 CFU
than ilium 31 ± 22 CFU, distal femur 14 ± 24 CFU and
proximal tibia 19 ± 5 CFU (Fig. 3d). The obtained p
values can be visualized in Additional file 1: Table S2.
Similarly, the mineralization capacity showed a similar
trend with a higher CFU-Ob potential in hMSCs isolated
from the ilium 12 ± 11 CFU-Ob (36% ± 18 CFU-Ob/CFU)
and proximal femur 11 ± 10 CFU-Ob (26% ± 16 CFU-Ob/
CFU) than distal femur 1 ± 1 CFU-Ob (13% ± 20 CFU-
Ob/CFU) and proximal tibia 5 ± 11 CFU-Ob (17%
±22 CFU-Ob/CFU) (Fig. 3h). The obtained p values can
be visualized in Additional file 1: Table S2. The high
standard deviation is attributed to the non-uniform
distribution over the donors (Fig. 3g).
The adipogenic potential of hMSCs showed a uniform
distribution for all the donors for BM aspirated from the
ilium and proximal femur but not from the distal femur
and proximal tibia (Fig. 3i). An average for all the donors
showed a significant increase in fat droplets in the prox-
imal tibia 21% ±6.85 when compared to the ilium 9%
±2.5. No statistical significant differences were observed
between the other groups (Fig. 3j).
Effect of acoustic stimulation on hMSCs
Self-renewal, proliferation, ECM production and multili-
neage potential (osteo- and adipogenic) were assessed
from the acoustic stimulated hMSCs.
Different BM volumes harvested from different donors
- 11.5 (donor 3), 10 (donor 5), 8 (donor 4), 6 (donor 1),
and 5 ml (donor 2) (Additional file 3: Figure S2A) - were
stimulated at a frequency of 300 Hz for 5 and 10 min
(Additional file 3: Figure S2B-F). Upon acoustic stimula-
tion a significant increase in CFU, mineralization and
adipogenesis was observed for hMSC isolated from small
BM volumes (5 and 6 mL) compared to larger volumes
(8, 10 or 11.5 ml). No statistical significant differences
were observed in proliferation or ECM production be-
tween the conditions. Based on the above-mentioned re-
sults subsequent experiments were performed using
small BM volumes (4 ml). An illustration of the device,
while 4 ml of BM is acoustic stimulated at 300Hz, is pre-
sented in Fig. 4.
Fig. 2 Characterization of BM aspirated (BMA) from different locations. a Correlation between aspirated BM volume and MNCs concentration, for the
ilium (circle) and proximal femur (square). b Correlation between the plated BM volumes and the number of isolated hMSCs, heterogeneous isolation
condition only. c BM viscosity curves from different aspiration locations, represented as correlation between the shear rate and the viscosity. The values
represented the mean ± standard deviation of three BM donors (n = 3). Statistically significant differences were found with ***p < 0.001 and **p < 0.01
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Acoustic stimulation of BM at 300 and 500 Hz for
5 and 10 min did not change hMSC proliferation be-
tween the conditions (Fig. 5A, B). In contrast, an in-
crease (not significant) in CFU, ECM production and
mineralization but not in adipogenic potential was
observed upon acoustic stimulation (Fig. 5c -j).
Surface marker expression on hMSCs isolated from
acoustic stimulated BM (300Hz for 5 min) showed a de-
crease, however not statistically significant, in expression
of positive surface markers such as CD105 (22 ± 3%
versus 32 ± 17%), CD90 (21 ± 5% versus 23 ± 7%), CD146
(3 ± 1% versus 4 ± 1%) and CD73 (20 ± 8% versus 23 ±
Fig. 3 Biological characterization of hMSCs isolated from different BM locations. a Proliferation of hMSCs calculated as PD/day from P1 to P2,
donor and location dependent. b Proliferation average for all the donors. c CFU potential of hMSCs, donor and location dependent. d CFU
average for all the donors. e ECM production, quantification of nodule size area in mm2 after cell condensation, donor and location dependent.
f ECM production average. g Osteogenic potential calculated as percentage of ALP positive colonies within the CFUs, donor and location
dependent. h Osteogenesis average. i Adipogenic potential, quantification of Oil red O staining relative to 100% Oil red O staining solution,
donor and location dependent. j Adipogenesis average. The uniform distribution of data, to test inter-donor variation, was assessed using
Chi-squared test and presented as a line above all donors. Values are represented as mean ± standard deviation of at least three independent
experiments (n≥ 3). Statistically significant differences were found with ***p < 0.001, **p < 0.01 and *p < 0.05
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17%), when compared to the baseline (Additional file 4:
Figure S3).
Effect of varying the initial culture condition on hMSCs
The isolation of hMSCs from the BM was assessed by
varying the initial culture conditions and their prolifera-
tion, ECM production, multilineage differentiation po-
tential and cell surface marker expression was analyzed.
No difference in proliferation (Fig. 6a, b and Additional
file 1: Table S3) and osteogenesis (Additional file 5:
Figure S4) was observed between the different isolation
conditions. In contrast, isolation of hMSCs under SF
condition showed a trend in increased ECM production,
with 4 out of 6 donors showing statistically significant
increase (Fig. 6c). When averaged for all the donors, p
values of 0.11 and 0.18 were obtained when compared to
heterogeneous and multiclonal conditions (Fig. 6d and
Additional file 1: Table S3). Additionally, SF condition
showed a trend in decreased adipogenesis, with 5 out of
6 donors showing a statistically significant decrease
(Fig. 6e). When averaged for all the donors p values of
0.48 and 0.13 were obtained when compared to hetero-
geneous and multiclonal conditions (Fig. 6f and Add-
itional file 1: Table S3). Isolation of hMSCs under
multiclonal condition showed a trend towards increased
adipogenesis (Fig. 6e). Statistically significant increase in
adipogenesis was observed in 5 out of 6 donors in multi-
clonal when compared to SF isolated hMSCs (Fig. 6e
and f, Additional file 1: Table S3).
The expression of CD271, CD34, CD14, CD79a, CD45
and HLA-DR was absent in all conditions regardless of
the isolation procedure, while no significant differences
where observed in the expression of CD90 (46 ± 31%
heterogeneous versus 36 ± 26% multiclonal and 43 ± 36%
serum free condition), CD105 (11 ± 6% heterogeneous
versus 23 ± 14% multiclonal and 34 ± 31% serum free
condition), CD73 (27 ± 7% heterogeneous versus 33 ±
18% multiclonal and 43 ± 33% serum free condition) and
CD146 (5 ± 4% heterogeneous versus 5 ± 4% multiclonal
and 11 ± 16% serum free condition) between the
isolation conditions. However, a trend towards higher
expression of CD105 (p =0.28), CD73 (p = 0.57) and
CD146 (p = 0.66) was observed in the hMSCs isolated in
SF media when compared to the heterogeneous
condition (Additional file 6: Figure S5). The high stand-
ard deviation is the result of inter-donor variation.
Discussion
The human body has an extensive capacity to regenerate
bone tissue after trauma. However, large defects cannot
be restored without intervention and often lead to non-
union. Long bone fracture repair has been extensively
studied at both clinical as well as fundamental level,
however little is known about the differences in fracture
repair between the femur and the tibia [6, 7]. Therefore
the aim of the present study was to assess the pool and
biological functions of BM-derived hMSCs in the lower
limbs, such as the ilium, proximal femur, distal femur
and proximal tibia. Additionally, we broadened our re-
search interest towards methods to prime BM-derived
hMSCs for later reimplantation at the fracture site. This
should facilitate their homing and commitment towards
a faster bone regeneration, as it has been already shown
Fig. 4 Acoustic stimulating device. a Sketch of the fluid flow within the processing chamber and the formation of a standing wave. b Processing
chamber. c Speaker, in white, located on the bottom of the processing chamber. d Standing wave pattern formed in bone marrow at 300Hz
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Fig. 5 (See legend on next page.)
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Fig. 5 Biological characterization of isolated hMSCs from acoustic stimulated BM at 300 and 500Hz for 5 and 10 min. The results are presented as the
fold change over the non-stimulated BM (baseline). a Proliferation of hMSCs calculated as PD/day from P1 to P2, donor and stimulation dependent. b
Proliferation average. c CFU potential of hMSCs, donor and stimulation dependent. d CFU average. e ECM production, quantification of nodule size
area in mm2, donor and stimulation dependent. f ECM production average. g Osteogenic potential calculated as percentage of ALP positive colonies
within the CFUs, donor and stimulation dependent. h Osteogenesis average. i Adipogenic potential, quantification of Oil red O staining relative to
100% Oil red O staining solution, donor and stimulation dependent. j Adipogenesis average. Values are represented as mean ± standard deviation of
at least three independent experiments (n≥ 3). Statistically significant differences were found with ***p < 0.001, **p < 0.01 and *p < 0.05
Fig. 6 Biological characterization of hMSCs isolated from BM under different isolation procedures a Proliferation of hMSCs calculated as PD/day
from P1 to P2, donor and isolation procedure dependent. b Proliferation average. c ECM production, percentage of formed nodules, donor and
isolation procedure dependent. d ECM production average. e Adipogenic potential, quantification of Oil red O staining relative to 100% Oil red O
staining solution, donor and isolation procedure dependent. f Adipogenesis average. Values are represented as mean ± standard deviation of at
least three independent experiments (n≥ 3). Statistically significant differences were found with ***p < 0.001 and **p < 0.01
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that a reduced pool of proliferative and multipotent
hMSCs are present at the low healing fractures [23].
In the present study we showed that the pool of BM-
derived hMSCs differ with respect to the BM aspiration
location. We found that after 14 days the number of
hMSCs isolated from the ilium and proximal femur was
higher (Fig. 2b) and they showed higher self-renewal and
osteogenic differentiation potential (Fig. 3d, f ) in compari-
son to hMSCs isolated from the distal femur and proximal
tibia, with the latter showing higher adipogenic potential.
These findings correspond to the macroscopic appearance
of the BM as described by Malkiewicz et al. [24], with red
BM found in the ilium and proximal femur, suggesting an
active participation to hematopoiesis, and yellow BM
found in distal femur and proximal tibia, which is
enriched in adipocytes. During aging, red marrow is re-
placed by yellow marrow and this change in the marrow
compartment might contribute to differences in the frac-
ture repair cascade [24]. In this context, we strongly be-
lieve that the differences in BFH rate between femur and
tibia are the result of insufficient amount of hMSCs
present at the fractured site, as well as their poor self-
renewal and osteogenic potential. Additionally, previous
studies demonstrated the use of bone marrow aspirate
and its efficacy in the treatment of fracture nonunion or
high nonunion rate repair [25, 26]. Therefore, we propose
that the isolation of BM from the ilium, and its delivery in
tibial fractures in order to enhance bone healing, could
improve the current clinical treatment strategy.
In the process of quantifying the concentration of
MNCs with regard to the aspirated BM volume, we found
that 10 ml of BM yields the highest MNC concentration.
Higher BM volumes yielded low concentrations of MNCs,
due to the dilution with peripheral blood during aspir-
ation, while lower BM volumes yielded also lower concen-
tration of MNCs, as described by Fennema EM et al. [27].
Interestingly, in both studies the same average concentra-
tion of MNCs (2.6*107 MNCs/ml) was found for 10 mL
aspirates, henceforth encouraging the surgeons to limit
the aspirated BM volume from the ilium to 10 ml.
In order to increase the contribution of cells to bone re-
pair, a new paradigm emerged in tissue regeneration, fo-
cusing on rhythms and oscillatory patterns capable of
orchestrating cell fate decision. The use of physical energy,
such as ultrasound vibration has shown to affect the cell
fate and increase the rate of bone repair [7, 28, 29], how-
ever the therapy has been rather inefficient likely due to
the low number of pro-regenerative cells present [6].
Therefore, we propose a different approach: the delivery
of acoustic stimulated BM from the ilium (rich in hMSCs)
at the fracture site. Based on a previous study by Ridgway
J. et al., where acoustic vibration was used to separate cells
from BM suspension, by trapping the cells in the pressure
node planes of the standing wave and reducing the
volume, an increase in CFU-Ob potential was observed in
the processed BM [22]. We believe that this increase was
not only due to the reduction in BM volume but also a
change in cell fate. To test this we selected two different
frequencies in the range of acoustic vibration, 300 and
500 Hz, and two time points 5 and 10 min. The results
obtained showed a trend towards an increased self-
renewal, ECM production and a shift towards osteogenic,
but not adipogenic, differentiation in acoustic stimulated
BM, suggesting that hMSCs may sense the acoustic vibra-
tory frequencies. However, the long expansion period ne-
cessary to obtain sufficient cell numbers to perform the
assays eventually led to a decrease in the multilineage po-
tential, as cell potential is known to diminish with in-
creased in vitro culture time [30, 31]. In addition, we
speculate that the decrease in positive hMSCs surface
markers in acoustically stimulated BM is the result of in-
tegrin reorganization (cellular mechanoreceptor on the
cell surface), followed by surface markers reorganization
[32] and change in cell fate. To our knowledge this is the
first study where acoustic energy was applied directly to
BM and not on cultured cells paving the way to its imple-
mentation into a one-step surgical procedure for bone re-
pair. The harvested BM can be first exposed to acoustic
stimulation during the surgical intervention followed by
administration to the fracture zone in cases where the
risk of nonunion is high or in revision surgeries for
pseudarthrosis.
While acoustic sound vibration focuses on changing
the phenotype of the cells, variation of the initial
hMSCs isolation conditions focuses on the selection of
a defined cell pool. We found that isolation of hMSCs
in SF media selects a pro-ECM cell population, which
could be of great help in accelerating the rebuilding
process of a native ECM after a bone fracture. In con-
trast, we found that isolation of hMSCs using low
MNC plating densities selects a pro-adipogenic cell
population. These findings underline the importance of
carefully selecting the right isolation procedure for the
right application.
Conclusion
Overall, our results suggest that novel approaches to bone
fracture healing can be developed based on our improved
understanding of bone marrow cell biology. Based on our
results we hypothesize that poor BFH in the tibia might
be the result of insufficient cell numbers as well as their
poor osteogenic potential. Based on this we suggest the
aspiration of BM from the ilium and its delivery into the
tibia to accelerate fracture healing. Moreover, we proposed
two new possible therapeutic approaches for BFH: acous-
tic stimulation of BM and use of preselected pro-ECM
hMSCs pool for delivery at the fracture site.
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